Influenza A and B viral hemagglutinin and neuraminidase surface antigens — Drug Target

1 drugs 1 marketed

All drugs that target Influenza A and B viral hemagglutinin and neuraminidase surface antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Prophylactic vaccine

Marketed (1)